Altered myocardial states. The stunned and hibernating myocardium

The American Journal of Medicine

Volumn 86, Issue 1 SUPPL. 1, 1989, Pages 14-22

  Kloner, Robert A ^a,b   Przyklenk, Karin ^a,b   Patel, Bharat ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; STUNNED HEART MUSCLE;

CORONARY CIRCULATION; CORONARY DISEASE; HEART; HUMAN; MYOCARDIAL CONTRACTION; MYOCARDIUM; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024553678     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(89)90005-3     Document Type: Article

References (80)

1. The stunned myocardium: prolonged, postischemic ventricular dysfunction
2. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina
3. Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”
4. Regional myocardial function and electrophysiological alterations after brief coronary artery occlusion in conscious dogs
5. Depression of regional blood flow and wall thickening after brief coronary occlusions
6. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion
7. Studies of experimental coronary artery reperfusion: effects of infarct size, myocardial function, biochemistry, ultrastructure, and microvascular damage
8. Regional differences in postischemic recovery in the stunned canine myocardium
9. Time course of recovery of “stunned” myocardium following variable periods of ischemia in conscious and anesthetized dogs
10. Diastolic abnormalities of postischemic “stunned” myocardium
11. Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated with anatomic evidence of necrosis
12. Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs
13. Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog
14. Coronary reperfusion for the treatment of acute myocardial infarction: postischemic ventricular dysfunction
15. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow
16. Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation
17. Inotropic stimulation of reperfused myocardium with dopamine: effects on infarct size and myocardial function
18. Beta-adrenergic stimulation reverses post-ischemic myocardial dysfunction without producing subsequent functional deterioration
19. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation
20. Calcium-induced increases in regional contractile function before and after transient coronary occlusion in the dog
21. The assessment of contractile reserve after thrombolytic therapy for acute myocardial infarction
22. Acute effects of hydralazine and enalapril on contractile function of postischemic “stunned” myocardium
23. Postextrasystolic potentiation predicts recovery of LV function in patients reperfused late after infarction
24. Sustained regional dysfunction produced by prolonged coronary stenosis: gradual recovery after reperfusion
25. Persistence of regional left ventricular dysfunction after exercise-induced myocardial ischemia
26. Disruption of myofibrillar energy use: dual mechanisms that may contribute to post-ischemic dysfunction in stunned myocardium
27. Oxygen-derived free radicals in postischemic tissue injury
28. Superoxide dismutase plus catalase improve contractile function in the canine model of “stunned myocardium”
29. Enhancement of recovery of myocardial function by oxygen-free radical scavengers after reversible regional ischemia
30. Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs
31. Attenuation of dysfunction in the postischemic “stunned” myocardium by dimethylhiourea
32. Evidence of a pathogenetic role of xanthine oxidase in the “stunned” myocardium
33. N-2-mercaptopropionylglycine improves recovery of myocardial function after reversible regional ischemia
34. The iron chelator desferrioxamine attenuates postischemic myocardial dysfunction
35. Enhancement of postischemic metabolic and functional recovery in the stunned canine myocardium by desferoxamine (DF)
36. 2+ transport in the post-ischemic “stunned” myocardium
37. Pathophysiology and pathogenesis of stunned myocardium
38. Are free radicals a major culprit?
39. Myocardial salvage by pharmacologic interventions
40. Effect of verapamil on post-ischemic “stunned” myocardium: importance of timing of treatment
41. Effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion
42. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog
43. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog
44. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog
45. Neutrophil depletion fails to attenuate post-ischemic myocardial dysfunction
46. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury
47. Microcirculatory disturbances in stunned myocardium
48. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional (“stunned”) but viable myocardium
49. A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction
50. Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction
51. Coronary artery reperfusion in acute myocardial infarction: beneficial effects of intracoronary streptokinase on left ventricular salvage and performance
52. Analysis of reported randomized trials of streptokinase therapy for acute myocardial infarction in the 1980s
53. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echocardiography
54. Exercise echocardiography a clinically practical addition in the evaluation of coronary artery disease
55. 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina
56. Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure-radius relations
57. Coronary vasospasm as a cause of stunned myocardium
58. Delayed recovery of severely “stunned” myocardium with the support of a left ventricular assist device after coronary artery bypass graft surgery
59. Postischemic myocardial “stunning”: a clinically relevant phenomenon
60. Determinants of reversible asynergy
61. Nitroglycerin to unmask reversible asynergy
62. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease
63. Depression of left ventricular function due to acute myocardial ischemia and its reversal after aortocoronary saphenous-vein bypass
64. Improved regional ventricular function after successful surgical revascularization
65. Postextrasystolic potentiation as a predictor of potential myocardial viability: preoperative analyses compared with studies after coronary bypass surgery
66. Immediate improvement of dysfunctional myocardial segments after coronary revascularization: detection by intraoperative transesophageal echocardiography
67. Response of the left ventricle in coronary artery disease to postextrasystolic potentiation
68. Detection of residual myocardial function in coronary artery disease using post-extra systolic potentiation
69. Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine
70. Reversal of rest myocardial asynergy during exercise
71. Preoperative prediction of reversible myocardial asynergy by postexercise radionuclide ventriculography
72. Determinants of reversible asynergy
73. Reversible asynergy
74. Reversibility of long-standing left ventricular aneurysm predicted by thallium-201 imaging
75. Ischemic cardiomyopathy: a clinicopathologic study of fourteen patients
76. Selection of angina-free patients with severe left ventricular dysfunction for myocardial revascularization
77. 18F-labeled fluorodeoxyglucose and N-13 ammonia
78. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography
79. Inotropic contractile reserve: a useful predictor of increased 5-year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction